Autoimmune Disease Diagnostics Market 2022: Revenue Growth, Key Factors, Major Companies, Forecast To 2032 with LeadingPosted by Bheru Kumar on May 5th, 2023 Highlighted with 87 tables and 103 figures, this 188-page report “Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) Global autoimmune disease diagnostics market will reach .81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies. The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region. In-depth qualitative analyses include identification and investigation of the following aspects:
"Maximize The Impact Of Your Data By Customizing Your Report With Our User-Friendly Tools." https://marketdatalibrary.com/free-customization/3893 Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Based on Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
o Antinuclear Antibody Tests o Anti-cyclic Citrullinated Peptide o Enzyme-Linked Immunosorbent Assay (ELISA) o Rheumatoid Factor o Thyroid Antibody Tests o Other Autoantibodies and Immunologic Tests
o C-Reactive Protein (CRP) o Erythrocyte Sedimentation Rate (ESR) o Other Inflammatory Marker Tests
o Urinalysis o Complete Blood Count (CBC) Tests o Other Routine Laboratory Tests
Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
o Rheumatoid Arthritis o Systemic Lupus Erythematosus (SLE) o Psoriasis/Psoriatic Arthritis o Other Systemic Autoimmune Diseases
o Thyroiditis o Multiple Sclerosis o Inflammatory Bowel Disease o Type 1 Diabetes o Other Localized Autoimmune Diseases Based on Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Based on Age, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Geographically, the following regions together with the listed national/local markets are fully investigated:
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Beckman Coulter, Inc. Biomerieux SA Bio-rad Laboratories Inc.
Hemagen Diagnostics Inc. Myriad Genetics Inc. PerkinElmer Inc. (Euroimmun AG) Quest Diagnostics Inc. Siemens Healthineers Inc. Thermo Fisher Scientific Inc. Trinity Biotech PLC Werfen Company (Inova Diagnostics Inc.) Read the Complete Report and TOC with Latest Developments: https://marketdatalibrary.com/report-store/global-autoimmune-disease-diagnostics-market-3893 About Market Data Library: Market Data Library is committed to providing clients with high-quality market research that is tailored to their specific needs. The Market Data Library provides corporate intelligence studies that ensure reliable and accurate research data across a diverse range of industries, including Health Care, Chemicals, Packaging, ICT, Automotive, Industrial Automation, Agriculture, and Finance. Our team is comprised of various departments, including sales, operations, finance, research, and analytics, as well as the scientist and data scientist teams. Our business offerings portray the most up-to-date, rational information a company needs to compete effectively. To guarantee that our clients have access to information and insights whenever they need them, we provide 24/7 research support. Contact Us Market Data Library Tel: +1-(718)-312-8686 Email: sales@marketdatalibrary.com Like it? Share it!More by this author
|